Second Opinion can be used to detect several dental conditions, including caries, discrepancies at the margin of existing restorations, tooth tartar and periapical radiolucency.
Pearl said the software exceeded the FDA’s efficacy requirements in four separate clinical studies, accurately identifying 36 percent more lesions than X-rays without AI assistance.
The software also has clearance in Europe, Canada, United Arab Emirates, Australia and New Zealand.
